Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, has joined. The National ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

In a recent conversation with Managed Healthcare Executive, Geoffrey Rutledge, M.D., of HealthTap, warned that the narrative around GLP-1 drugs is often oversimplified—and potentially harmful.

In 2024, top issues included daily work activities, work-life balance and conflict with managers. Now in 2025, those concerns ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In a recent discussion with Managed Healthcare Executive, three leading dermatologists and itch experts—Shawn Kwatra, M.D., ...

Women who undergo menopause before the age of 40 are more likely to experience cognitive decline, which may lead to dementia, ...

Republicans are aiming for major reductions in federal spending, and Medicaid seems a likely target. But the politics of ...

The complete response letter did not identify any issues with the safety or efficacy of Eylea HD, Regeneron officials said.

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...